<?xml version="1.0" encoding="UTF-8"?>
<p>We would like to thank Marie-Paule Kieny, Larisa Rudenko, Martin Friede, Erin Grace Sparrow, Guido Torelli from WHO, Sit Thirapakpoomanunt, Suwit Wibulpolprasert, the Oversight Committee and staff of vaccine production of the Thai Government Pharmaceutical Organization (GPO), the Ministry of Public Health, Thailand, for their contributions to the Influenza Vaccine study; all the study volunteers for their participation; WHO for technical and financial support provided through a grant from US BARDA; the Institute of Experimental Medicine, St Petersburg, Russia for providing the master seed and performing the immune response assay in part 1 of the study; Microgen (Moscow, Russia) for providing the inactivated influenza vaccine used in part 2; the clinical and nursing staff at the Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; and the laboratory staff at the Department of Microbiology, Siriraj Hospital, Mahidol University.</p>
